HHS to provide $23 million to Merck for Ebola vaccine production

FILE PHOTO: A health worker fills a syringe with Ebola vaccine before injecting it to a patient, in Goma, Democratic Republic of Congo, August 5, 2019. REUTERS/Baz Ratner/File Photo

(Reuters) – The U.S. Department of Health and Human Services (HHS) said on Wednesday it will fund the manufacturing of Merck & Co Inc’s investigational Ebola vaccine called V920, in response to the outbreak of the deadly virus in the Democratic Republic of the Congo (DRC). The Ebola hemorrhagic fever has killed at least 1,900 […]

Continue reading this article with a Fiji Times online membership.

More Stories